ALSEN Sensorion SA

8.362USD7.624 EUR · EPA-1.00%Mkt Cap: 86.18M USDP/E: —

Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy developm…

Key Statistics

Company
Market Cap86.18M USD
Enterprise Value-7.38M USD
Revenue (TTM)6.75M USD
Gross Profit6.75M USD
Net Income (TTM)-32.28M USD
Revenue/Share0.86 USD
Last Price8.362 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR001401A9Z0
Valuation
P/E (Trailing)—
P/E (Forward)-3.40
PEG—
EV/EBITDA0.20
EV/Revenue-1.09
P/S12.77
P/B0.96
EPS (TTM)-5.10 USD
EPS (Forward)-2.46 USD
52W Range
5.7577% of range44.31
52W High44.31 USD
52W Low5.757 USD
Profitability
Gross Margin100.00%
Oper. Margin-574.54%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-66.16%
ROA-50.84%
ROIC—
ROCE-66.97%
Growth
Revenue Growth14.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.92M USD
CapEx (TTM)829.18K USD
FCF Margin-285.75%
FCF Yield-22.38%
Net Debt-93.55M USD
Net Debt/EBITDA2.48
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio8.00
Quick Ratio7.91
Book Value/Sh8.68 USD
Cash/Share9.42 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateSep 15, 2026
Analyst Consensus
Rating—
Target (Mean)44.09 USD
Upside (mean)+427.3%
Target Range35.10 USD – 54.84 USD
35.10+427.3% to mean54.84
# Analysts5
Ownership
Shares Out.10.31M
Float3.72M
Insiders34.76%
Institutions32.64%
Technical
SMA 508.728 (-4.2%)
SMA 20016.43 (-49.1%)
Beta0.49
S&P 52W Chg12.00%
Avg Vol (30d)16.07K
Avg Vol (10d)8.49K
Technical Indicators
RSI (14)39.8
MACD-0.1132
MACD Signal0.0064
MACD Hist.-0.1196
BB Upper10.46 USD
BB Middle9.400 USD
BB Lower8.341 USD
BB Width22.51%
ATR (14)0.5426 USD
Vol Ratio (20d)1.08x

About Sensorion (EPA: ALSEN)

›

Sensorion (EPA: ALSEN) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 66 employees.

The shares were at 7.624 EUR on 19 November 2026, down 55.0% over 52 weeks. Its 52-week range is 5.249 EUR to 40.40 EUR: the price is 81.1% below the high and 45.2% above the low.

Its market capitalisation is 78.58M EUR.

Sensorion reports return on equity of -66.2% and revenue up 14.7% year over year.

It holds more cash than debt, a net cash position of 85.30M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.